Prostate cancer
Mayo Clinic is a world leader in prostate cancer treatment and research and has curated a large repository of prostate cancer information, including an extensive store of clinMayo Clinic is a world leader in prostate cancer treatment and research. It has curated a large repository of prostate cancer information, including an extensive store of clinical data and tissue and serum samples.
The key to curing prostate cancer is early diagnosis. Thanks to improved screening and early detection, prostate cancer is often diagnosed when the cancer is still contained within the prostate. This often allows a cure through surgery or radiation.
Our researchers are committed to improving options for urologic cancers such as prostate cancer. We conduct research to better understand cancer biology and to find ways to better target cancer cells with both surgical and nonsurgical approaches.
Areas of research in prostate cancer include:
- Novel urine-based diagnostic techniques to identify clinically significant prostate cancer.
- Biomarkers for prognosis after treatment with prostatectomy or radiation.
- Regulation of the androgen receptor gene in prostate cancer cells and other androgen-regulated cells.
- Identification of genes in normal and malignant prostate tissue using electronic profiling of expressed sequence tags and DNA microarray chip technology.
- Detecting prostate cancer with different forms of prostate-specific genes.
- Minimally invasive image-guided interventions.
- Radioligand therapy to target cancer cells.
- Neoadjuvant therapy in clinically localized high-risk prostate cancer.
- Advancements in imaging of prostate cancer for diagnostic and intraoperative detection.
- Innovative MRI diagnosis for prostate cancer detection.
Related information